Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Persistently low alkaline phosphatase (ALP) most often points to hypophosphatasia (HPP), an inherited condition in which ALPL gene mutations leave the TNSALP enzyme unable to clear inorganic pyrophosphate, so bone mineral cannot form normally and bones stay soft, painful, and fracture-prone. The same enzyme defect explains related signs such as early loss of baby teeth, delayed walking, muscle weakness, kidney stones, and stress fractures that heal slowly.
Standard medical next steps include repeating ALP using age and sex specific reference ranges, measuring vitamin B6 and urine phosphoethanolamine, confirming with ALPL genetic testing, and referral to a metabolic bone specialist, since treatments like bisphosphonates and high dose vitamin D can worsen HPP. Severity, inheritance pattern, and non-genetic causes of low ALP vary
Alkaline phosphatase (ALP) is an enzyme essential for normal bone formation and mineralization. When ALP levels are abnormally low—a condition known as hypophosphatasia—bone strength and structure can suffer. Inherited mutations in the ALPL gene underlie the most severe form of low ALP, leading to lifelong challenges with bone health. This article explains why low ALP causes genetic bone weakness, outlines common and rare causes of low ALP, and highlights the next steps for diagnosis and management.
When ALP activity is insufficient, PPi accumulates, preventing proper mineralization. Over time, bones can become soft, fragile or misshapen.
Accumulation of PPi
• Excess PPi binds to calcium and phosphate, blocking crystal growth in bone.
• Impaired crystal deposition results in weak, poorly mineralized bone.
Defective Osteoid Mineralization
• The unmineralized osteoid layer thickens.
• Bones are prone to deformities, fractures and chronic pain.
Dental Complications
• Cementum (tooth-supporting tissue) also relies on ALP.
• Low ALP can cause early tooth loss and delayed tooth eruption.
Severity Linked to Mutation Type
• Over 300 ALPL gene mutations identified.
• Severe enzyme deficiency leads to lethal perinatal forms, milder mutations cause adult or childhood forms.
While genetic hypophosphatasia is the leading inherited cause, other factors can lower ALP levels:
• Genetic Hypophosphatasia
– Autosomal recessive or dominant mutations in ALPL.
– Subtypes range from perinatal (often fatal) to odonto-hypophosphatasia (mainly dental issues).
• Nutritional Deficiencies
– Severe malnutrition or protein-calorie deficiency.
– Zinc deficiency can reduce ALP synthesis.
• Endocrine Disorders
– Hypothyroidism may mildly lower ALP.
– Adrenal insufficiency in rare cases.
• Chronic Illnesses
– Pernicious anemia and severe anemia of other causes.
– Use of certain medications (e.g., bisphosphonates) may transiently affect ALP.
• Genetic Carrier Status
– Heterozygous carriers of ALPL mutations may have borderline low ALP with mild symptoms.
Low ALP doesn’t always cause obvious symptoms, but genetic forms often present with:
• Frequent fractures (even with minor trauma)
• Bone pain and muscle weakness
• Short stature or bowed limbs in children
• Delayed walking or gross motor skills
• Early loss of baby teeth, loose permanent teeth
• Joint pain and arthritis-like symptoms in adults
• Recurrent respiratory infections in severe infantile forms
If you experience bone pain, frequent fractures or dental issues without a clear cause, keep low ALP on your radar.
Blood Tests
Urine Biochemistry
Genetic Testing
Imaging Studies
Specialist Evaluation
While there’s no “one-size-fits-all” cure, several approaches can improve outcomes:
• Enzyme Replacement Therapy (ERT)
– Asfotase alfa (Strensiq®) is FDA-approved for pediatric and adult hypophosphatasia.
– Improves bone mineralization, respiratory function and survival in severe cases.
• Nutritional Support
– Adequate calcium and vitamin D intake under medical supervision.
– Monitor for hypercalcemia; vitamin B6 (pyridoxine) supplementation if needed.
• Physical Therapy and Rehabilitation
– Tailored exercises to strengthen muscles and support mobility.
– Orthotics or braces for limb deformities.
• Pain Management
– Non-steroidal anti-inflammatory drugs (NSAIDs) or acetaminophen.
– Avoid bisphosphonates—they can worsen mineralization defects.
• Dental Care
– Early and regular dental check-ups.
– Custom mouthguards to protect loose teeth.
• Genetic Counseling
– Discuss inheritance patterns, carrier testing for relatives.
– Family planning advice for future pregnancies.
Monitor Symptoms
• Track bone pain, height/weight changes and dental issues.
• Notice any new fractures or delayed milestones in children.
Free Symptom Check
• Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
• Ubie helps you prioritize concerns before your medical visit.
Consult Your Healthcare Team
• Share blood test results and symptom history with your primary doctor.
• Request referral to an endocrinologist or geneticist if hypophosphatasia is suspected.
Discuss Treatment Options
• Ask about eligibility for enzyme replacement therapy.
• Review nutritional strategies and physical therapy plans.
Family Screening
• Encourage at-risk relatives to get tested if a genetic cause is confirmed.
• Early diagnosis can prevent complications.
Speak to a doctor right away if you or a loved one experience:
• Severe bone pain or inability to move a limb after minor trauma
• Signs of hypercalcemia (nausea, vomiting, confusion)
• Respiratory distress in infants (rapid breathing, poor feeding)
• Seizures or loss of consciousness
These symptoms warrant urgent evaluation to rule out life-threatening complications.
Your bones deserve expert attention. If you suspect low ALP or genetic bone weakness, start with a clear symptom log, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker, and reach out to your healthcare provider to discuss further testing and treatment options. Stay proactive, stay informed, and never hesitate to speak to a doctor about anything that could be serious.
(References)
* Inoue M. [Hypophosphatasia]. Nihon Rinsho. 2006 Jun 28;Suppl 2:104-7. PMID: 16817361.
* Beck C, Morbach H, Stenzel M, Schneider P, Collmann H, Girschick G, Girschick HJ. [Hypophosphatasia]. Klin Padiatr. 2009 Jul-Aug;221(4):219-26. doi: 10.1055/s-0029-1220718. Epub 2009 Jul 23. PMID: 19629901.
* Chen H, Han Y, Li X, Liu X, Feng W, Xu W. Hypophosphatasia. Skeletal Radiol. 2013 Feb;42(2):295-6, 317-8. doi: 10.1007/s00256-012-1456-8. PMID: 22729426.
* Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Marini JC, Dang Do AN. Osteogenesis Imperfecta. 2000. PMID: 25905334.
* Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017 Sep;122(1-2):4-17. doi: 10.1016/j.ymgme.2017.07.010. Epub 2017 Jul 25. PMID: 28888853.
* Polyzos SA, Mantzoros CS. Outliers of bone metabolic diseases. Metabolism. 2018 Mar;80:1-4. doi: 10.1016/j.metabol.2017.09.009. Epub 2017 Oct 4. PMID: 28987276.
* Briot K, Roux C. Adult hypophosphatasia. Arch Pediatr. 2017 May;24(5S2):5S71-5S73. doi: 10.1016/S0929-693X(18)30018-6. PMID: 29405936.
* Cianferotti L. Osteomalacia Is Not a Single Disease. Int J Mol Sci. 2022 Nov 28;23(23). doi: 10.3390/ijms232314896. Epub 2022 Nov 28. PMID: 36499221; PMCID: PMC9740398.
* Reis FS, Lazaretti-Castro M. Hypophosphatasia: from birth to adulthood. Arch Endocrinol Metab. 2023 May 25;67(5):e000626. doi: 10.20945/2359-3997000000626. PMID: 37249457; PMCID: PMC10665056.
* MacCarrick G, Aradhya S, Bailey M, Chu D, Hunt A, Izzo E, Krakow D, Mackenzie W, Poll S, Raggio C, Shediac R, White KK, McLaughlin HM, Seratti G. Clinical utility of comprehensive gene panel testing for common and rare causes of skeletal dysplasia and other skeletal disorders: Results from the largest cohort to date. Am J Med Genet A. 2024 Sep;194(9):e63646. doi: 10.1002/ajmg.a.63646. Epub 2024 May 3. PMID: 38702915.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.